Adolor Corp (ADLR) SEC Filing 10-K Annual report for the fiscal year ending Monday, December 31, 2007

Adolor Corp

CIK: 1076167 Ticker: ADLR

Exhibit 99.1






Adolor Corporation

    Sam Brown, Inc. (media)

Thomas P. Hess, CPA

    Mike Beyer (773) 463-4211

Vice President, Finance and CFO


(484) 595-1500




— Delta Program Update Provided —

EXTON, PA, February 29, 2008

— Adolor Corporation (Nasdaq: ADLR) today reported financial results for the year and fourth quarter ended December 31, 2007 and provided an update on its Delta Program.

2007 Financial Results

For the twelve months ended December 31, 2007, the company reported a net loss of $48.4 million or $(1.05) per basic and diluted share, compared to a net loss of $69.7 million, or $(1.56) per basic and diluted share for the same period in 2006. For the three month period ended December 31, 2007, the company reported a net loss of $10.1 million or $(0.22) per basic and diluted share, compared to a net loss of $18.4 million or $(0.40) per basic and diluted share in the three months ended December 31, 2006.

“We enter 2008 with two strong lead development programs, increasing momentum in discovery research, and a solid financial foundation,” said Michael R. Dougherty, president and chief executive officer of Adolor Corporation. “With our PDUFA date for Entereg on May 10, 2008, we await the FDA’s completion of its review of our NDA for postoperative ileus. We look ahead to realizing our objective of making this important new product available to patients in the near future.”

“A highlight of the fourth quarter of 2007 was our collaboration with Pfizer Inc for the Delta Program,” continued Dougherty. “Pfizer shares our vision for this program, the development of an entirely new class of opioid receptor agonists, and our joint efforts are now well underway. Finally, we are increasingly enthusiastic about our early discovery and research programs, and believe our efforts here will lead to the identification of new development candidates for our growing pipeline.”

The following information was filed by Adolor Corp (ADLR) on Friday, February 29, 2008 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one year to another to evaluate Adolor Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Adolor Corp.


Assess how Adolor Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Adolor Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors